Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine

NCT01842230 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension
Hyperlipidemia

Interventions

DRUG: Telmisartan 80mg, S-amlodipine 5mg and Atorvastatin 40mg
DRUG: Telmisartan 80mg and S-amlodipine 5mg

Sponsor

Chong Kun Dang Pharmaceutical